Exelixis
EXEL
#1325
Rank
$16.10 B
Marketcap
$66.01
Share price
0.27%
Change (1 day)
56.64%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company